PFG Advisors’s Inspire Medical Systems INSP Stock Holding History

PFG Advisors’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,946	Closed	-$763K	–	511
2021 Q2	$763K	Buy	+3,946	New	+$783K	0.09%	268

Other funds holding INSP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

PFG Advisors's INSP Position: Q3 2021 in Review

PFG Advisors sold out of Inspire Medical Systems (INSP) in Q3 2021, closing a stake of 3,946 shares — an estimated $763K sold.

PFG Advisors first reported a position in INSP in Q2 2021 and held it in 1 quarter. The position peaked at $763K in Q2 2021. 252 funds tracked by Wall St. Rank hold INSP as of Q3 2021.

PFG Advisors reported no remaining Inspire Medical Systems position as of Q3 2021 after selling out during the quarter.
PFG Advisors sold 3,946 Inspire Medical Systems shares in Q3 2021, an estimated $763K.
PFG Advisors first reported a position in Inspire Medical Systems in Q2 2021 and held it in 1 quarter.
PFG Advisors's Inspire Medical Systems position peaked at $763K in Q2 2021.
252 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2021.

Based on PFG Advisors's 13F filing for Q3 2021, filed 5 Nov 2021.